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From the Field

Alfaxalone Successfully Immobilizes Small
Indian Mongooses (Urva auropunctata):
A Field Report
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ABSTRACT We investigated intramuscular administration of alfaxalone (5.3–10.0 mg/kg) as an

immobilizing agent in free‐ranging small Indian mongooses (Urva auropunctata) on the island of St.
Kitts, West Indies. From 5–11 January 2020, we successfully immobilized 10 of 11 mongooses.
Alfaxalone provided rapid onset (median = 3 min) of immobilization. Mean duration of immobilization
was 16.8 ± 3 min. Mean recovery time was 5.6 ± 1 min. There was no eﬀect of dose administered
on induction, anesthesia, or recovery times at the dose range used. We concluded that alfaxalone represents
an eﬀective alternative to dissociative agents for the immobilization of free‐ranging mongooses.
Further studies are necessary to quantify alfaxalone eﬀects on mongoose vital rates and blood parameters.
© 2021 The Wildlife Society.
KEY WORDS alfaxalone, chemical immobilization, small Indian mongoose, Urva auropunctata, wildlife immobilization.

Immobilization of free‐ranging wildlife is carried out for a
variety of management and conservation purposes such as
disease surveillance, translocation, health monitoring, and
other research objectives. However, immobilization of
free‐ranging wild animals can be challenging as it is often
conducted in remote locations and with limited availability
of vital‐sign monitoring equipment. Upon immobilization,
animal health status and body weight are generally
unknown, suggesting that drugs used should have a wide
safety margin, although rapid delivery of small volumes
necessitates potent concentrated drugs (Fahlman 2008).
Additionally, a drug with either an antagonist or short recovery time to full mobility may reduce potential predation
following anesthesia.
The most commonly used anaesthetic drugs in wild carnivores are the dissociative anaesthetics ketamine and tiletamine
combined with either a benzodiazepine (e.g., tiletamine‐
zolazepam) or an alpha‐2‐agonist (e.g., ketamine‐xylazine
or ketamine‐medetomidine; Fahlman 2008, Kreeger and
Arnemo 2018). Although common protocols have been
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demonstrated to be eﬀective and relatively safe, dissociative
anaesthetics are controlled substances in several countries,
complicating use in international or transboundary studies.
Moreover, in the context of frequent drug shortages, the
veterinary ﬁeld is encouraged to develop alternative protocols
for routine procedures.
Alfaxalone is a synthetic neuroactive steroid that is
approved for intravenous (IV) induction or maintenance of
general anesthesia in cats and dogs (Rezende 2015). However, oﬀ‐label use by the intramuscular (IM) route has been
described in dogs, cats and rabbits (Huynh et al. 2015,
Tamura et al. 2015a, b, Maney 2017, Cruz‐Benedetti
et al 2018). Recently, IM administration of alfaxalone was
reported to rapidly induce immobilization in reptiles
(Kischinovsky et al. 2013, Hansen and Bertelsen 2013) and
captive marmosets (Callithrix jacchus; Bakker et al. 2013).
Interspeciﬁc variation in response to drugs is common;
therefore it is important that research be carried out for each
species of interest to identify the most suitable drugs and
dosages (Pearson et al. 1968). The small Indian mongoose
(Urva auropunctata) is an opportunistic carnivore native to
Southern Asia and parts of the Middle East that was introduced to a number of Caribbean and Paciﬁc islands
during the late 19th and early 20th centuries (Hinton and
Dunn 1967, Nellis and Everard 1983). There is increasing
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interest in mongoose immobilization for research and
management purposes, as mongooses represents a substantial threat to several native species in tropical ecosystems
(Berentsen et al. 2017). Moreover, the small Indian mongoose is the principal wildlife reservoir for canine rabies in
several Caribbean islands, representing a serious public
health concern (Seetahal et al. 2018).
Mongooses are typically immobilized by IM injection of
tiletamine‐zolazepam (5 mg/kg; e.g., Johnson et al. 2016) or
a 50:1 mixture of ketamine:xylazine (Choudhary
et al. 2013). The objective of our study was to assess
whether alfaxalone, administered IM, could be a suitable
alternative to dissociative agents for undertaking minor
procedures such as morphological measurements and blood
collection in free‐ranging small Indian mongooses.

STUDY AREA
We conducted our study from 5–11 January 2020, on the
island of St. Kitts, West Indies. The study site was a
0.5‐km2 plot of subtropical dry forest dominated by small
trees and shrubs including river tamarind (Leucaena
leucocephala), Croton spp. and Acacia spp., with an understory of herbaceous plants such as buttonsage (Lantana
involucrata), bull nettle (Cnodoscolus urens) and Guinea
grass (Panicum maximum; Lindsay and Horwith 1999).
The climate was tropical marine, with an average
annual temperature of 27.8°C with little seasonal variation
(CARICOM et al. 1993). Average annual rainfall was
1,625 mm, most of which occurs from August to November
(CARICOM et al. 1993). St. Kitts is free from terrestrial
rabies and no cases have been reported in mongooses or any
other mammalian species (Seetahal et al. 2018).

METHODS
We live‐captured mongooses using cage traps (Tomahawk
Live Trap, Hazelhurst, WI, USA) baited with canned tuna.
Traps were baited daily in the morning and checked within
24 hours. Upon capture, we transferred mongooses into a
conical canvas bag where they were physically restrained.
We immobilized captured mongooses via intramuscular
injection of alfaxalone (Alfaxan, Vetoquinol B.V., Breda, NL;
10 mg/mL) at a targeted dose of 6–12 mg/kg. The dose range
was derived from intramuscular doses of 5 and 12 mg/kg
reported for successful sedation in cats and marmosets,
respectively (Bakker et al. 2013; Rodrigo‐Mocholi et al. 2018)
and considering that wildlife species usually require higher
doses than domestic animals due to the stress associated with
handling (Fahlman 2008). Because animal weight could only
be determined after immobilization, the handler estimated
the dose volume based on animal size, and calculated the
actual dose administered a posteriori. All capture, handling and
immobilization procedures were approved by the Animal
Use Ethics Committee of University of Montreal (CÉUA
19‐Rech‐1945).
After immobilization we collected morphological data
including sex, weight (±25 g; Ohaus 8004‐MN spring scale,
Parsippany, NJ) and nose‐tail length (±1 mm; soft tape
measure) and inserted a Passive Integrated Transponder
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(PIT) tag (Biomark APT12 FDX_B, Boise, Idaho, USA)
via subcutaneous injection for individual animal identiﬁcation. We recorded induction, immobilization, and recovery times. We deﬁned induction time as the time elapsed
between injection and the loss of postural tonicity.
Immobilization time was deﬁned as the time elapsed
between loss of postural tonicity and ﬁrst return of muscle
tonicity (e.g., limb movement or rigidity). Recovery time
represented the time elapsed between resumption of muscle
tonicity and regained ambulatory function. We collected up
to 1.0 mL of blood by venipuncture of the cranial vena cava
as described for ferrets (Briscoe and Syring 2004). Given the
remote and rugged terrain of the study site, vital‐sign
monitoring equipment was unavailable during immobilization, thus, speciﬁc vital parameters (e.g., blood pressure,
oxygen saturation) could not be measured. However,
animals were regularly observed for changes in respiration
and ocular position, an indicator of depth of anesthesia, and
veriﬁed every minute until recovery.
We assessed the eﬀects of dose on immobilization duration using robust linear models using the MASS and sfsmisc
packages in R (Venables and Ripley 2002, R Core
Team 2019, Maechler 2020). Induction, immobilization
and recovery times were response variables and dose
administered was the ﬁxed eﬀect. Data was tested for normality using the Shapiro‐Wilk test and we present results as
means ± standard errors (SE) for normally‐distributed
variables, and as median values otherwise. Statistical
signiﬁcance was determined at α = 0.05.

RESULTS
We evaluated alfaxalone in 11 mongooses at doses ranging
from 5.3 to 10.0 mg/kg, as calculated following administration once animals were immobilized and weighed.
Alfaxalone resulted in successful immobilization of 10 of
11 mongooses. One mongoose demonstrated light sedation
but retained muscle tone and voluntary movement until
it walked away 20 mins post‐injection (Table 1). The
10 immobilized mongooses displayed ventromedial rotation
of the eyeball throughout the immobilization phase, indicating an appropriate plane of anesthesia (Stage III, light
to medium planes; Soma 1971). Median induction time was
3 min (range = 2–11 min, n = 10). Mean (SE) immobilization time was 16.8 (3) min (range = 4–38 min), which was
suﬃcient for all morphological measurements and biological
sample (blood) collection to be performed. All immobilized
animals fully recovered, with a mean (SE) recovery time of
5.6 (1) min (range = 0–14 min). Animal handling did not
result in any detectable injury, and no adverse eﬀect of
alfaxalone administration was observed during the procedure or upon animal release. One mongoose was recaptured
2 days following alfaxalone administration and displayed no
signs of injury or altered behaviour.
There was no eﬀect of the dose administered on induction,
immobilization or recovery times (Fig. 1) over the range of
dosages used in our study. Median induction times were
lower for males (2 min, n = 4) than females (3 min, n = 6).
Likewise, mean immobilization and recovery times were all
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Table 1. Individual characteristics, dose administered and induction, immobilization and recovery times for 11 free‐ranging small Indian mongooses
immobilized by intramuscular injection of alfaxalone (10 mg/mL) on the island of St. Kitts in January 2020.
Date
05
07
07
08
08
09
09
10
10
11
11

Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan

2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020

Sex

Weight (g)

Dose volume
(mL)

Dose administered
(mg/kg)

Induction time
(min)

Immobilization time
(min)

Recovery time
(min)

M
F
F
F
F
M
M
M
F
F
F

550
375
500
375
425
475
550
425
450
300
425

0.4
0.2
0.3
0.25
0.25
0.3
0.3
0.25
0.3
0.3
0.3

7.27
5.33
6.00
6.67
5.88
6.32
5.45
5.88
6.67
10.00
7.06

3
NA
3
4
3
2
2
2
11
2
3

18
NA
20
17
10
17
16
7
4
21
38

8
NA
14
6
7
7
0
1
6
7
0

lower for males (n = 4) than females (n = 6). Sex‐speciﬁc
diﬀerences were not statistically signiﬁcant (Table 2);
however, sample size limited statistical power, thus, an
eﬀect of mongoose sex on immobilization and recovery
times cannot be excluded.

DISCUSSION
Our study suggests that alfaxalone represents a potential
alternative to dissociative agents for the chemical immobilization of wild small Indian mongooses. Alfaxalone resulted
in successful immobilization of 10 of 11 of the animals
tested. Alfaxalone has beneﬁts compared with classic
mongoose immobilization protocols (i.e., not a controlled
substance in some countries, eﬃcient as a single agent).
However, unlike benzodiazepines and alpha‐2‐agonists

Figure 1. Alfaxalone dose (mg/kg) administered to free‐ranging small
Indian mongooses on the island of St. Kitts in January 2020, related to
induction (grey circles), immobilization (black circles), and recovery (blue
circles) times (min). No signiﬁcant eﬀect was found using linear regression
for induction (t8 = −0.23, P = 0.82), immobilization (t8 = 0.96, P = 0.34),
or recovery times (t8 = 0.61, P = 0.55), represented by grey, black and blue
dashed lines, respectively.
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present in drug combinations commonly used for wildlife
immobilization, alfaxalone is not reversible. When used
intravenously to induce anesthesia, alfaxalone is typically
administered to eﬀect. To eﬀect administration is not possible when a drug is injected intramuscularly because of the
increased delay of action associated with this route. It is
therefore important to identify and use minimal eﬀective
doses. The lowest dose used in our study (5.3 mg/kg)
appeared to be insuﬃcient as it only induced partial immobilization, whereas doses at 5.45 mg/kg and up to
10.0 mg/kg successfully induced immobilization. Our dose
range therefore represents a starting point to guide eventual
dose‐response studies in mongooses, which are necessary to
determine species speciﬁc optimal alfaxalone doses. In
addition, dose volumes (0.5–1.2 mL/kg) must be taken into
account when considering the IM use of alfaxalone. It is
generally considered that IM administration should be limited
to animals weighing less than 10 kg (Nieuwendijk 2011).
Alfaxalone can also be used in combination with other drugs
such as benzodiazepines and opioids to reduce dose volumes
required (e.g. Lee et al. 2015).
No formal comparisons in induction, immobilization and
recovery times were attempted between classic dissociative
anaesthetics and alfaxalone in our study. However, it is our
impression based on previous ﬁeld observations that alfaxalone generally resulted in similar durations of the induction
and immobilization phases, but a shorter recovery phase,
than anaesthesia with tiletamine‐zolazepam. Although there
was a delay between return of muscle tonicity and recovery
of reﬂexes in all 10 mongooses successfully immobilized
with alfaxalone in our study, the later phase of recovery was

Table 2. Mean (±1 SE) immobilization and recovery times associated
with the intramuscular injection of alfaxalone in female (n = 6) and male
(n = 4) Indian mongooses on the island of St. Kitts in January 2020. The t‐
statistics, degrees of freedom (DF) and P‐values shown are from Welch
two sample t‐test on means.
Duration (min)

Females

Males

t‐value

DF

P‐value

Immobilization
time
Recovery time

18.3 ± 3.7

11.6 ± 1.6

0.71

7.28

0.50

6.67 ± 1.8

4.00 ± 2.0

0.98

7.01

0.36
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rapid, with animals typically opening their eyes, regaining
their righting reﬂex, and walking away within a few seconds.
Our results were consistent with what has been reported in
marmosets, in that alfaxalone (12 mg/kg) resulted in
equivalent immobilization durations, but lower recovery
times, than ketamine alone (100 mg/kg) or ketamine
(25 mg/kg) combined with medetomidine (0.5 mg/kg)
(Bakker et al. 2013).
The single mongoose that was not successfully immobilized received the lowest dose of alfaxalone administered in
our study (5.3 mg/kg); however, other mongooses that received similar doses (5.45 and 5.89 mg/kg; Table 1) were
successfully immobilized. We believe the failure of alfaxalone to immobilize this individual illustrates interindividual
variation in response to the drug at the lower limit of the
dose range used in our study. Injection of a second dose was
not attempted because the mongoose was not suﬃciently
sedated to be weighed in order to calculate the required
additional dose. In the dose range that successfully resulted
in immobilization (5.45–10 mg/kg), induction, immobilization, and recovery times were not related to the dose
administered, suggesting that alfaxalone clearance is rapid
and not saturated at these doses in mongooses. Similarly,
in dogs alfaxalone plasma clearance and volume of
distribution did not diﬀer between IV doses of 2 and
10 mg/kg (Ferré et al. 2006).
Our study represents an assessment of the eﬃcacy of alfaxalone in immobilization of small Indian mongooses. Our
study was opportunistic in nature and took place during a
concurrent mongoose population density study. The study
took place in remote and rugged ﬁeld location accessible
only on foot, prohibiting the transportation of equipment
required to monitor vital parameters that would typically
be performed in a more controlled laboratory setting.
Nonetheless, basic parameters such as respiration, pulse
(apex beat) and ocular position were monitored at 1 to
5‐min intervals, and no adverse eﬀects on these parameters
were observed. Therefore, additional studies conducted in a
controlled environment comparing immobilization time for
alfaxalone and the dissociative anaesthetics regularly used to
immobilize mongooses are needed to optimize alfaxalone
doses for use in mongooses. Likewise, alfaxalone eﬀects on
mongoose vital rates and blood parameters (e.g., indicators
of muscle damage; Bakker et al. 2013) should be investigated. Additionally, increasing sample size would allow
investigation of sex‐speciﬁc optimal doses. Although captive
settings are ideal for such studies, one must be aware that
free‐ranging animals may require higher doses than their
captive relatives due to capture and handling induced stress
(Fahlman 2008).
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